Global Drugs for Vulvovaginal Candidiasis Competitive Landscape Professional Research Report 2024

Research Summary

Drugs for vulvovaginal candidiasis, commonly known as vaginal yeast infections, are medications used to treat fungal infections caused by Candida species in the vaginal area. Antifungal drugs such as topical creams, suppositories, or oral tablets containing agents like clotrimazole, miconazole, or fluconazole are commonly prescribed or available over-the-counter to alleviate symptoms like itching, burning, and abnormal discharge. These medications work by targeting the yeast cells, disrupting their growth and replication. The choice of drug and treatment duration depends on factors such as the severity of the infection, recurrence history, and patient preferences, with healthcare professionals guiding appropriate treatment approaches for effective relief.

According to DIResearch's in-depth investigation and research, the global Drugs for Vulvovaginal Candidiasis market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Drugs for Vulvovaginal Candidiasis include Bayer, Perrigo, Johnson & Johnson, Pfizer, Bristol-Myers Squibb, Effik, Teva, Cisen Pharmaceutical, Sanofi, Kingyork Group etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Drugs for Vulvovaginal Candidiasis. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Drugs for Vulvovaginal Candidiasis market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Drugs for Vulvovaginal Candidiasis market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Drugs for Vulvovaginal Candidiasis industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Drugs for Vulvovaginal Candidiasis Include:

Bayer

Perrigo

Johnson & Johnson

Pfizer

Bristol-Myers Squibb

Effik

Teva

Cisen Pharmaceutical

Sanofi

Kingyork Group

Drugs for Vulvovaginal Candidiasis Product Segment Include:

Cream

Pessary

Other

Drugs for Vulvovaginal Candidiasis Product Application Include:

External Treatment

Internal Treatment

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Drugs for Vulvovaginal Candidiasis Industry PESTEL Analysis

Chapter 3: Global Drugs for Vulvovaginal Candidiasis Industry Porter's Five Forces Analysis

Chapter 4: Global Drugs for Vulvovaginal Candidiasis Major Regional Market Size and Forecast Analysis

Chapter 5: Global Drugs for Vulvovaginal Candidiasis Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Drugs for Vulvovaginal Candidiasis Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Drugs for Vulvovaginal Candidiasis Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Drugs for Vulvovaginal Candidiasis Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Drugs for Vulvovaginal Candidiasis Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Drugs for Vulvovaginal Candidiasis Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Drugs for Vulvovaginal Candidiasis Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Drugs for Vulvovaginal Candidiasis Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Drugs for Vulvovaginal Candidiasis Market Overview

1.1 Product Definition and Statistical Scope

1.2 Drugs for Vulvovaginal Candidiasis Product by Type

1.2.1 Global Drugs for Vulvovaginal Candidiasis Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Cream

1.2.3 Pessary

1.2.4 Other

1.3 Drugs for Vulvovaginal Candidiasis Product by Application

1.3.1 Global Drugs for Vulvovaginal Candidiasis Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 External Treatment

1.3.3 Internal Treatment

1.4 Global Drugs for Vulvovaginal Candidiasis Market Revenue Analysis (2019-2030)

1.5 Drugs for Vulvovaginal Candidiasis Market Development Status and Trends

1.5.1 Drugs for Vulvovaginal Candidiasis Industry Development Status Analysis

1.5.2 Drugs for Vulvovaginal Candidiasis Industry Development Trends Analysis

2 Drugs for Vulvovaginal Candidiasis Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Drugs for Vulvovaginal Candidiasis Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Drugs for Vulvovaginal Candidiasis Market Analysis by Regions

4.1 Drugs for Vulvovaginal Candidiasis Overall Market: 2023 VS 2024 VS 2030

4.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Region (2019-2024)

4.2.2 Global Drugs for Vulvovaginal Candidiasis Revenue Forecast by Region (2025-2030)

5 Global Drugs for Vulvovaginal Candidiasis Market Size by Type and Application

5.1 Global Drugs for Vulvovaginal Candidiasis Market Size by Type

5.2 Global Drugs for Vulvovaginal Candidiasis Market Size by Application

6 North America

6.1 North America Drugs for Vulvovaginal Candidiasis Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Drugs for Vulvovaginal Candidiasis Market Size by Type

6.4 North America Drugs for Vulvovaginal Candidiasis Market Size by Application

6.5 North America Drugs for Vulvovaginal Candidiasis Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Drugs for Vulvovaginal Candidiasis Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Drugs for Vulvovaginal Candidiasis Market Size by Type

7.4 Europe Drugs for Vulvovaginal Candidiasis Market Size by Application

7.5 Europe Drugs for Vulvovaginal Candidiasis Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Drugs for Vulvovaginal Candidiasis Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Drugs for Vulvovaginal Candidiasis Market Size by Type

8.4 China Drugs for Vulvovaginal Candidiasis Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Drugs for Vulvovaginal Candidiasis Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Drugs for Vulvovaginal Candidiasis Market Size by Type

9.4 APAC (excl. China) Drugs for Vulvovaginal Candidiasis Market Size by Application

9.5 APAC (excl. China) Drugs for Vulvovaginal Candidiasis Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Drugs for Vulvovaginal Candidiasis Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Drugs for Vulvovaginal Candidiasis Market Size by Type

10.4 Latin America Drugs for Vulvovaginal Candidiasis Market Size by Application

10.5 Latin America Drugs for Vulvovaginal Candidiasis Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Drugs for Vulvovaginal Candidiasis Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Drugs for Vulvovaginal Candidiasis Market Size by Type

11.4 Middle East & Africa Drugs for Vulvovaginal Candidiasis Market Size by Application

11.5 Middle East & Africa Drugs for Vulvovaginal Candidiasis Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Drugs for Vulvovaginal Candidiasis Market Revenue by Key Manufacturers (2020-2024)

12.2 Drugs for Vulvovaginal Candidiasis Competitive Landscape Analysis and Market Dynamic

12.2.1 Drugs for Vulvovaginal Candidiasis Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Bayer

13.1.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Bayer Drugs for Vulvovaginal Candidiasis Product Portfolio

13.1.3 Bayer Drugs for Vulvovaginal Candidiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Perrigo

13.2.1 Perrigo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Perrigo Drugs for Vulvovaginal Candidiasis Product Portfolio

13.2.3 Perrigo Drugs for Vulvovaginal Candidiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Johnson & Johnson

13.3.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Johnson & Johnson Drugs for Vulvovaginal Candidiasis Product Portfolio

13.3.3 Johnson & Johnson Drugs for Vulvovaginal Candidiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Pfizer

13.4.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Pfizer Drugs for Vulvovaginal Candidiasis Product Portfolio

13.4.3 Pfizer Drugs for Vulvovaginal Candidiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Bristol-Myers Squibb

13.5.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Product Portfolio

13.5.3 Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Effik

13.6.1 Effik Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Effik Drugs for Vulvovaginal Candidiasis Product Portfolio

13.6.3 Effik Drugs for Vulvovaginal Candidiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Teva

13.7.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Teva Drugs for Vulvovaginal Candidiasis Product Portfolio

13.7.3 Teva Drugs for Vulvovaginal Candidiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Cisen Pharmaceutical

13.8.1 Cisen Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Product Portfolio

13.8.3 Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Sanofi

13.9.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Sanofi Drugs for Vulvovaginal Candidiasis Product Portfolio

13.9.3 Sanofi Drugs for Vulvovaginal Candidiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Kingyork Group

13.10.1 Kingyork Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Kingyork Group Drugs for Vulvovaginal Candidiasis Product Portfolio

13.10.3 Kingyork Group Drugs for Vulvovaginal Candidiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Drugs for Vulvovaginal Candidiasis Industry Chain Analysis

14.2 Drugs for Vulvovaginal Candidiasis Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Drugs for Vulvovaginal Candidiasis Typical Downstream Customers

14.4 Drugs for Vulvovaginal Candidiasis Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support